Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för rivaroxaban. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

39 träffar

Bibliografisk träff 2012-04-26

Accurate determination of rivaroxaban levels requires different calibrator sets but not addition of antithrombin.

Mani H, Rohde G, Stratmann G, Hesse C, Herth N, Schwers S, Perzborn E, Lindhoff-Last E.

Thromb Haemost · research support, non-u.s. gov't; evaluation study; journal article · DOI 10.1160/th11-12-0832

Bibliografisk träff 2012-03-02

Evaluation of the prothrombin time for measuring rivaroxaban plasma concentrations using calibrators and controls: results of a multicenter field trial.

Samama MM, Contant G, Spiro TE, Perzborn E, Flem LL, Guinet C, Gourmelin Y, Martinoli JL, Rivaroxaban Prothrombin Time Field Trial Laboratories.

Clin Appl Thromb Hemost · comparative study; clinical trial; research support, non-u.s. gov't; multicenter study; journal article · DOI 10.1177/1076029611426282

Bibliografisk träff 2012-03-01

Rivaroxaban vs. warfarin for stroke prevention in patients with nonvalvular atrial fibrillation.

Darby-Stewart A, Dachs R, Graber MA.

Am Fam Physician · comment; journal article

Bibliografisk träff 2012-02-17

Determination of rivaroxaban in human plasma samples.

Harenberg J, Erdle S, Marx S, Krämer R.

Semin Thromb Hemost · journal article · DOI 10.1055/s-0032-1301415

Bibliografisk träff 2012-02-01

Rivaroxaban: a review of its use for the prophylaxis of venous thromboembolism after total hip or knee replacement surgery.

Duggan ST.

Am J Cardiovasc Drugs · review; journal article · DOI 10.2165/11208470-000000000-00000

Bibliografisk träff 2012-01-01

Evaluation of prothrombin complex concentrate and recombinant activated factor VII to reverse rivaroxaban in a rabbit model.

Godier A, Miclot A, Le Bonniec B, Durand M, Fischer AM, Emmerich J, Marchand-Leroux C, Lecompte T, Samama CM.

Anesthesiology · journal article · DOI 10.1097/aln.0b013e318238c036

Bibliografisk träff 2012-01-01

Upcoming oral factor Xa inhibitors for venous thromboembolism prophylaxis in patients undergoing major orthopedic surgery: rivaroxaban (Xarelto) and apixaban (Eliquis) review.

Lee S, White CM.

Conn Med · review; journal article

Bibliografisk träff 2011-12-21

Evaluation of the anti-factor Xa chromogenic assay for the measurement of rivaroxaban plasma concentrations using calibrators and controls.

Samama MM, Contant G, Spiro TE, Perzborn E, Guinet C, Gourmelin Y, Le Flem L, Rohde G, Martinoli JL, Rivaroxaban Anti-Factor Xa Chromogenic Assay Field Trial Laboratories.

Thromb Haemost · research support, non-u.s. gov't; multicenter study; evaluation study; journal article · DOI 10.1160/th11-06-0391

Bibliografisk träff 2011-12-01

Rivaroxaban (Xarelto) for acute coronary syndrome.

Författaruppgift saknas

Med Lett Drugs Ther · journal article